H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Census population 269,840. Wisconsin Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Madison clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Madison storefront.
Alternatives to Joint Replacement Surgery in Madison, WI for clinics & physicians. Non-surgical alternativ… Compliance support & pricing — contact Hawk Medical.
7.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Population 269,840. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and J6 documentation are ready before the first application of non surgical alternatives to joint replacement.
National Alternatives to Joint Replacement Surgery notes (how the product actually works)7.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 269,840 residents will still mix those payers. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Adult arthritis here is 17% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Madison.
CDC PLACES (2023, crude prevalence) estimates 7.4% of adults — 4.6 points below the U.S. 12% figure. Obesity is 32.7%; arthritis is 17%. That is place-level BRFSS modeling, not a clinic census and not a Madison trial.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Wisconsin clinician.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Wisconsin. There is no Madison storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Madison, WI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Madison is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Madison — 4.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Wisconsin Part B wound biologics follow this contractor (siblings: IL, MN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Madison. Useful for joint-program math; still needs a diagnosis and privileging.
No Madison storefront. Joe Bradley is an active practice owner. non surgical alternatives to joint replacement stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.